Benjamin, Ronald
Berges, Bradford K.
Solis-Leal, Antonio
Igbinedion, Omoyemwen
Strong, Christy L.
Schiller, Martin R.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (AI109156, AI116411)
Article History
Received: 29 February 2016
Accepted: 29 April 2016
First Online: 12 May 2016
Compliance with ethical standards
:
: Martin R. Schiller and Christy L. Strong have a patent pending for using TALENs to treat HIV, and thus have a potential conflict of interest.